Three cases of severely disseminated Staphylococcus aureus infection in patients treated with tocilizumab
about
Tocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis.C reactive protein may not be reliable as a marker of severe bacterial infection in patients receiving tocilizumab.Assay of Blood and Synovial Fluid of Patients With Rheumatoid Arthritis for Staphylococcus aureus Enterotoxin D: Absence of Bacteria But Presence of Its Toxin.A new alternative therapy in dermatology: tocilizumab.Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy.A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis.Genetic Variation in TLR10, an Inhibitory Toll-Like Receptor, Influences Susceptibility to Complicated Skin and Skin Structure Infections.
P2860
Q34924736-1342B996-C176-4DB5-952C-425585A47638Q38157586-89CA41DF-CCC3-4BA9-A012-4AB6AD810186Q38303443-3AC32F09-D17A-4FC2-90FF-E227AEF67C49Q38507301-FC4B6F52-E880-4FA3-9436-2F96490B1C2CQ39337664-F8E76C64-F570-4B4C-BE71-186A4B0E3424Q40118329-66418393-A198-42AF-BF8F-D02E72EF56E9Q41304611-9C87B3D5-94AF-4133-AC5E-D29BD7F7C7DB
P2860
Three cases of severely disseminated Staphylococcus aureus infection in patients treated with tocilizumab
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Three cases of severely dissem ...... ients treated with tocilizumab
@ast
Three cases of severely dissem ...... ients treated with tocilizumab
@en
type
label
Three cases of severely dissem ...... ients treated with tocilizumab
@ast
Three cases of severely dissem ...... ients treated with tocilizumab
@en
prefLabel
Three cases of severely dissem ...... ients treated with tocilizumab
@ast
Three cases of severely dissem ...... ients treated with tocilizumab
@en
P2860
P356
P1433
P1476
Three cases of severely dissem ...... ients treated with tocilizumab
@en
P2093
Jan Pødenphant
Pernille Ravn
P2860
P356
10.1136/BCR-2012-007413
P577
2013-01-02T00:00:00Z